PE CORP
S-8 POS, EX-5.2, 2000-06-12
LABORATORY ANALYTICAL INSTRUMENTS
Previous: PE CORP, S-8 POS, 2000-06-12
Next: PE CORP, S-8 POS, EX-23, 2000-06-12




Exhibit 5.2



                         [Simpson Thacher Letterhead]


                                                                 June 9, 2000



PE Corporation
761 Main Avenue
Norwalk, Connecticut  06859

Ladies and Gentlemen:

              We have acted as counsel to PE Corporation, a Delaware

corporation ("PE"), in connection with Post-Effective Amendment No. 1 on Form

S-8 to the Registration Statement on Form S-4 (Registration No. 333-35080) of

PE (the "Registration Statement"), filed with the Securities and Exchange

Commission under the Securities Act of 1933, as amended, relating to

shares (the "Shares") of PE Corporation - Celera Genomics Group Common Stock,

par value $.01 per share, of PE to be issued by PE pursuant to the Paracel,

Inc. Stock Option Plan (the "Plan") of Paracel, Inc., a California

corporation ("Paracel") such Plan of Paracel to be assumed by PE pursuant to

the Agreement and Plan of Merger, dated as of March 20, 2000 (the "Merger

Agreement"), among PE, Paracel and Umbrella Acquisition Corp., a wholly-owned

subsidiary of PE.

              We have examined the Plan and the Merger Agreement.  In

addition, we have examined, and have relied as to matters of fact upon,

originals, or duplicates or certified or conformed copies, of such corporate

records, agreements, documents and other instruments and such certificates or

<PAGE>

comparable documents of public officials and of officers and representatives

of PE, and have made such other and further investigations, as we have deemed

relevant and necessary as a basis for the opinions hereinafter set forth.

              In such examination, we have assumed the genuineness of all

signatures, the legal capacity of natural persons, the authenticity of all

documents submitted to us as originals, the conformity to original documents

of all documents submitted to us as duplicates or certified or conformed

copies, and the authenticity of the originals of such latter documents.

              Based upon the foregoing, and subject to the qualifications and

limitations stated herein, we are of the opinion that the Shares have been

duly authorized and, upon the issuance of the Shares in accordance with the

terms of the applicable Plan and payment of the consideration, if any,

payable therefor pursuant to terms of the applicable Plan, such Shares will

be validly issued, fully paid and nonassessable.

              We are members of the Bar of the State of New York, and we do

not express any opinion herein concerning any law other than the Delaware

General Corporation Law.















                                      -2-

<PAGE>

              We hereby consent to the filing of this opinion of counsel as

Exhibit 5.2 to the Registration Statement.

                                              Very truly yours,



                                              SIMPSON THACHER & BARTLETT





































                                      -3-




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission